Clinical Trials Study
Copyright ©The Author(s) 2017.
World J Gastroenterol. Dec 14, 2017; 23(46): 8217-8226
Published online Dec 14, 2017. doi: 10.3748/wjg.v23.i46.8217
Table 1 Characteristics of subjects n (%)
Healthy,(n = 10)Post-LT
Uncomplicated, (n = 10)NAS,(n = 10)
Age (yr)38 ± 1243 ± 1142 ± 9
Male9 (90.0)8 (80.0)8 (80.0)
BMI (kg/m2)23.3 ± 2.522.1 ± 2.622.4 ± 2.7
Current smoking3 (30.0)2 (10.0)0
Current drinking2 (20.0)00
Blood routine test
HB (g/L)122.5 ± 12.7129.0 ± 20.0127.4 ± 9.0
WBC (×109)6.0 ± 1.75.1 ± 2.25.2 ± 2.5
Neu (%)59.6 ± 14.866.4 ± 16.464.3 ± 20.0
Liver function
AST (U/L)21.3 (7.9-39.6)41.0 (13.0-93.0)57.1 (17.0-107.0)ac
ALT (U/L)20.1 (14.6-34.4)49.3 (12.0-89.1)57.3 (18.0-111.0)ac
ALP (U/L)77.3 ± 31.793.9 ± 17.2332.8 ± 52.4ac
GGT (U/L)27.2 ± 8.253.3 ± 35.6226.4 ± 83.4ac
TB (μmol/L)13.7 ± 6.727.4 ± 17.6104.43 ± 47.8ac
DB (μmol/L)5.4 ± 3.112.5 ± 8.643.8 ± 6.8ac
ALB (g/L)41.1 ± 2.941.9 ± 5.334.1 ± 5.0ac